Canada’s SOR/2026-162 will save $27,675 per qualifying drug submission by allowing Health Canada to rely on U.S. FDA and EMA reviews. The change means an $18,07

BWB News TV • 2026-07-25 17:36 UTC • By Billy Odell Tucker-Robinson

Canada’s SOR/2026-162 will save $27,675 per qualifying drug submission by allowing Health Canada to rely on U.S. FDA and EMA reviews. The change means an $18,075 benefit versus a $9,600 cost per filing, marking a deregulatory shift.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly